Guilin Sanjin Pharmaceutical Co., Ltd.
Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; …
Biotechnology
CN, Guilin [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q1 | Q3 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 19.66 | 3.80 | 3.18 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -72.02 | -6.30 | -3.66 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q1 | Q3 | Δ in % | |
|---|---|---|---|---|
| Book Value | 3.79 | 5.13 | 4.94 | |
| Cash | 7.34 | 2.41 | 2.25 | |
| Capex | 263.55 | 0.06 | -0.02 | |
| Free Cash Flow | -23.65 | 0.02 | 0.03 | |
| Revenue | 5.07 | 0.86 | 0.82 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q1 | Q3 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 1.12 | 0.75 | 0.74 | |
| Operating Margin | -17.80 | 0.22 | 0.26 | |
| ROA | -19.81 | 0.02 | 0.03 | |
| ROE | -20.04 | 0.03 | 0.03 | |
| ROIC | -20.04 | 0.02 | 0.03 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of 002275.SZ is permitted for members.
5
Growth
The "Growth Entry" for the Focus of 002275.SZ is permitted for members.
6
Leverage & Liquidity